StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Equities research analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Sunday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Price Performance

Shares of MLSS stock opened at $0.95 on Friday. The firm has a market cap of $73.37 million, a P/E ratio of -9.50 and a beta of 1.08. The stock’s 50-day moving average is $0.96 and its two-hundred day moving average is $0.77. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.10.

Milestone Scientific (NYSE:MLSS) last posted its earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The company had revenue of $1.85 million for the quarter. Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%.

Insider Activity

In related news, Director Leonard Osser sold 141,913 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total value of $134,817.35. Following the completion of the transaction, the director now directly owns 4,602,506 shares in the company, valued at $4,372,380.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 24.75% of the stock is owned by company insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.